
Indride M 1mg/500mg Tablet SR
Marketer
Indmark Biotech Private Limited
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Indride M 1mg/500mg Tablet SR
Metformin/Glibenclamide 500mg/1mg Extended-Release Tablets are classified as antidiabetic agents. This combination medication treats type 2 diabetes in adults by helping regulate blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical supervision risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are integral to diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect. Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to manage them. Maintain regular meals and carry a rapid-acting glucose source (e.g., sugary snacks, juice). Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your doctor before starting treatment. Pregnant or lactating individuals should seek medical counsel prior to use. Regular blood glucose monitoring is essential, and your physician may order blood tests to assess blood cell counts and liver function.
Primary Ingredients of Indride M 1mg/500mg Tablet SR
No text provided. Please provide the text you wish me to rephrase.
Uses of Indride M 1mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Indride M 1mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not crush, chew, or divide it. Consume Indride M 1mg/500mg Extended-Release tablets with food.
Common Side effects of Indride M 1mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Indride M 1mg/500mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Indride M 1mg/500mg Extended-Release tablets should be administered with a meal.
How Indride M 1mg/500mg Tablet SR works:
Indride M 1mg/500mg Extended-Release tablets combine glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose production, retarding intestinal glucose absorption, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Indride M 1mg/500mg SR tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Indride M 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Extended-release Indride M 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.
DrivingCAUTION
Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
For individuals with kidney impairment, Indride M 1mg/500mg SR tablets require careful administration, potentially necessitating dosage modification. Severe kidney disease contraindicates the use of Indride M 1mg/500mg SR tablets. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Indride M 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician before use. A reduced initial dose is typically recommended for individuals with mild to moderate hepatic dysfunction; the medication is unsuitable for those with severe liver disease.
What if you forget to take Indride M 1mg/500mg Tablet SR :
Should you forget to take a dose of Indride M 1mg/500mg SR tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Indride M 1mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
